BioCentury | Oct 29, 2008
Company News

Receptor BioLogix names Pfost CEO, raises $6M

...Previously, Pfost was president, CEO and chairman of ophthalmic company Acuity , which reverse-merged with eXegenics...
BioCentury | Sep 29, 2008
Product Development

Ophthalmic deals

...potential $5M investment. Mar 07 Acuity/Froptix/eXegenics NA Acuity and Froptix reverse merge with shell company eXegenics...
BioCentury | Jun 11, 2007
Company News

Opko, Ophthalmic Technologies Inc. deal

...EVP of instrumentation. In March, Acuity Pharmaceuticals Inc. and Froptix Corp. reverse-merged with shell company eXegenics Inc....
BioCentury | Apr 2, 2007
Finance

Ebb & Flow

...in reverse Macular degeneration companies Acuity and Froptix announced they would merge with shell company eXegenics...
...About $16 million will come from the remaining cash held by EXEG. Formerly known as Cytoclonal...
BioCentury | Apr 2, 2007
Company News

Acuity, eXegenics, Froptix Corp. deal

...merged company plans to list its shares on AMEX. Acuity Pharmaceuticals Inc. , Philadelphia, Penn. eXegenics Inc....
BioCentury | Sep 13, 2004
Company News

eXegenics, NLC Pharma Inc. deal

...NLC to third parties. QCT is based on quantum chemistry, computational software and molecular modeling. eXegenics Inc....
BioCentury | Apr 12, 2004
Company News

eXegenics management update

eXegenics Inc. (EXEG), Dallas, Texas Business: Cancer, Infectious Promoted: David Riggs to president and CEO from VP and CBO; he will retain his title of CFO WIR Staff...
BioCentury | Mar 1, 2004
Company News

eXegenics management update

eXegenics Inc. (EXEG), Dallas, Texas Business: Cancer, Infectious Resigned: Ronald Goode as president and CEO WIR Staff cancer Infectious...
BioCentury | Nov 17, 2003
Company News

eXegenics board of directors update

eXegenics Inc. (EXEG), Dallas, Texas Business: Cancer, Infectious Appointed: Gordon Martin, formerly CFO of NASDAQ Stock Market Inc. WIR Staff cancer Infectious...
BioCentury | Sep 15, 2003
Company News

eXegenics, EI Acquisition Inc., Foundation Growth Investments LLC deal

...Ore.). AVII also terminated its bid for EXEG earlier this month (see BioCentury, Sept. 8). eXegenics Inc....
Items per page:
1 - 10 of 77
BioCentury | Oct 29, 2008
Company News

Receptor BioLogix names Pfost CEO, raises $6M

...Previously, Pfost was president, CEO and chairman of ophthalmic company Acuity , which reverse-merged with eXegenics...
BioCentury | Sep 29, 2008
Product Development

Ophthalmic deals

...potential $5M investment. Mar 07 Acuity/Froptix/eXegenics NA Acuity and Froptix reverse merge with shell company eXegenics...
BioCentury | Jun 11, 2007
Company News

Opko, Ophthalmic Technologies Inc. deal

...EVP of instrumentation. In March, Acuity Pharmaceuticals Inc. and Froptix Corp. reverse-merged with shell company eXegenics Inc....
BioCentury | Apr 2, 2007
Finance

Ebb & Flow

...in reverse Macular degeneration companies Acuity and Froptix announced they would merge with shell company eXegenics...
...About $16 million will come from the remaining cash held by EXEG. Formerly known as Cytoclonal...
BioCentury | Apr 2, 2007
Company News

Acuity, eXegenics, Froptix Corp. deal

...merged company plans to list its shares on AMEX. Acuity Pharmaceuticals Inc. , Philadelphia, Penn. eXegenics Inc....
BioCentury | Sep 13, 2004
Company News

eXegenics, NLC Pharma Inc. deal

...NLC to third parties. QCT is based on quantum chemistry, computational software and molecular modeling. eXegenics Inc....
BioCentury | Apr 12, 2004
Company News

eXegenics management update

eXegenics Inc. (EXEG), Dallas, Texas Business: Cancer, Infectious Promoted: David Riggs to president and CEO from VP and CBO; he will retain his title of CFO WIR Staff...
BioCentury | Mar 1, 2004
Company News

eXegenics management update

eXegenics Inc. (EXEG), Dallas, Texas Business: Cancer, Infectious Resigned: Ronald Goode as president and CEO WIR Staff cancer Infectious...
BioCentury | Nov 17, 2003
Company News

eXegenics board of directors update

eXegenics Inc. (EXEG), Dallas, Texas Business: Cancer, Infectious Appointed: Gordon Martin, formerly CFO of NASDAQ Stock Market Inc. WIR Staff cancer Infectious...
BioCentury | Sep 15, 2003
Company News

eXegenics, EI Acquisition Inc., Foundation Growth Investments LLC deal

...Ore.). AVII also terminated its bid for EXEG earlier this month (see BioCentury, Sept. 8). eXegenics Inc....
Items per page:
1 - 10 of 77